What are the emerging disease-modifying therapies for Alzheimer's disease, and how do these innovations impact diagnostic approaches?
Abstract
Emerging disease-modifying therapies for Alzheimer's disease, such as monoclonal antibodies and stem cell therapies, are advancing along with AI-driven diagnostic innovations. These developments may lead to improved disease management and earlier diagnosis, though further evaluation is needed to establish long-term efficacy and safety.
Fields of Study & Subjects
Alzheimer's disease research and treatments
Dementia and Cognitive Impairment Research
Cholinesterase and Neurodegenerative Diseases
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 15 January 2026